Rhumbline Advisers Has $19.91 Million Stake in Bath & Body Works, Inc. (NYSE:BBWI)

Rhumbline Advisers lifted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 38.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 513,546 shares of the company’s stock after purchasing an additional 142,753 shares during the quarter. Rhumbline Advisers owned 0.24% of Bath & Body Works worth $19,910,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Golden State Wealth Management LLC acquired a new position in shares of Bath & Body Works in the fourth quarter valued at $26,000. UMB Bank n.a. raised its stake in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares in the last quarter. True Wealth Design LLC raised its stake in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after purchasing an additional 1,054 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Bath & Body Works in the third quarter valued at $39,000. Finally, Friedenthal Financial acquired a new position in shares of Bath & Body Works in the fourth quarter valued at $57,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have weighed in on BBWI. Argus reiterated a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Piper Sandler increased their target price on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Telsey Advisory Group restated an “outperform” rating and set a $43.00 target price on shares of Bath & Body Works in a report on Thursday. Finally, JPMorgan Chase & Co. upgraded Bath & Body Works from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $41.00 to $47.00 in a report on Tuesday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.63.

Bath & Body Works Trading Up 0.6 %

NYSE:BBWI opened at $40.33 on Friday. The stock has a market cap of $8.73 billion, a P/E ratio of 9.84, a PEG ratio of 0.96 and a beta of 1.83. The stock has a 50 day simple moving average of $37.70 and a 200 day simple moving average of $33.81. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period last year, the firm posted $0.48 EPS. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 1.98%. Bath & Body Works’s payout ratio is 19.51%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.